Emerging applications for ferumoxytol as a contrast agent in MRI

Explore this paper's citation graph

Summary

Since ferumoxytol is an iron‐based agent with no potential for causing nephrogenic systemic fibrosis, it may be useful as an alternative to gadolinium‐based contrast agents in patients with compromised renal function.

Type
review
Published
2015-04-01
Cited by
346
References
102
Access
Open access

Keywords

Ferumoxytol, Nephrogenic systemic fibrosis, Medicine, Magnetic resonance imaging, Gadolinium

References

Cited by

Related papers